Skip to content
Open access

Oxidative Stress and Inflammatory Cytokines as Drivers of Cardiac Remodeling in COPD Patients

Sep 2026 · Antioxidants · Vol 15 · 0 citations · 103 references
Medicine

TL;DR

Systemic inflammatory markers were associated with structural and electrical cardiac abnormalities in COPD, suggesting that they may provide complementary information regarding cardiovascular involvement, but given the cross-sectional design and moderate discriminatory performance, the findings should be considered exploratory and do not establish causal relationships.

Abstract

Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic disease characterized by chronic inflammation and oxidative stress, with frequent cardiovascular involvement. This study investigated the associations between oxidative stress-related inflammatory markers and structural and electrical cardiac abnormalities in patients with COPD using a comprehensive multimodal cardiopulmonary assessment. A total of 100 clinically stable patients with COPD underwent inflammatory biomarker evaluation (IL-6, IL-8, IL-1β, and TNF-α), transthoracic echocardiography and 24 h Holter ECG monitoring. Advanced COPD was associated with significant differences in several structural cardiac parameters, including left atrial volume (p = 0.016), left atrial height (p = 0.027), and selected left ventricular parameters, while left ventricular ejection fraction remained preserved. Electrical abnormalities were significantly associated with systemic inflammatory markers. SII showed the highest discriminatory performance for sinus rhythm abnormalities (AUC = 0.736), whereas IL-6 showed the highest discriminatory performance for ventricular premature complexes (AUC = 0.732). Ventricular ectopic activity was also associated with significantly higher SII, SIRI, MLR, NLR, and PLR. Systemic inflammatory markers were associated with structural and electrical cardiac abnormalities in COPD, suggesting that they may provide complementary information regarding cardiovascular involvement. However, given the cross-sectional design and moderate discriminatory performance of these biomarkers, the findings should be considered exploratory and do not establish causal relationships. Prospective studies are needed to determine their potential role in cardiovascular risk stratification.

Read PDF

Similar papers

Open access Sep 2026

Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden

Background/Objectives: Systemic inflammation is a widely recognised feature of chronic obstructive pulmonary disease (COPD). The combined contribution of acute-phase reactants and pro-inflammatory cytokines to disease severity and exacerbation risk remains incompletely understood. This study evaluated the associations...

Oana Maria Catană, Ramona Cioboată, D. Mitroi et al. · 0 citations
Oct 2026

Estimation of Endothelin Levels in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension: A Clinical Insight.

BACKGROUND Chronic obstructive pulmonary disease (COPD) is a major global health issue, with pulmonary hypertension (PH) as a severe complication linked to increased morbidity and mortality. Endothelin-1 (ET-1) is a vasoconstrictor peptide and a potential biomarker for PH in COPD due to its role in vascular remodeling...

J. Bajpai, Akshyaya Pradhan, Mohammed Kaleem Ahmad et al. · 0 citations
Open access Oct 2026

How Innate Immune Mechanisms Contribute to the Chronic Nature of COPD?

Background Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent inflammation, airflow limitation, and progressive tissue destruction. While smoking is a major risk factor, recent research links innate immune mechanisms, oxidative stress, and protease imbalances to disease chronicity. Objectives T...

B. M. Khashman, Yasir M. Abdulateef, H. N. Eyada · 0 citations
Open access Sep 2026

Pathways of oxidative stress and inflammation integration in the pathogenesis of vascular calcification in patients with chronic kidney disease

BACKGROUND. Vascular and cardiac calcification is an important contributor to cardiovascular complications in patients with chronic kidney disease (CKD) and is associated with oxidative stress and persistent low-grade inflammation. However, the interactions between these processes and their contribution to cardiovascul...

F. Dzgoeva, I. В. Tedety, O. Remizov et al. · 0 citations
Oct 2026

Beyond hemodynamic failure: a distinct inflammatory cytokine profile in cardiogenic shock complicating acute coronary syndrome.

OBJECTIVE To compare the clinical, hemodynamic, metabolic and inflammatory profiles of patients with acute coronary syndrome (ACS) with and without cardiogenic shock (CS) and to identify biomarkers associated with disease severity. METHODS In this observational study, 76 patients with ACS (38 with CS and 38 without C...

Ankur Mittal, Kraticka Singhal, Akash Batta et al. · 0 citations
Open access Aug 2026

EVALUATION OF THE ROLE OF URIC ACID, CREATININE RATIO, AND ALBUMIN-CREATININE RATIO AS PROGNOSTIC MARKERS IN ASSESSING SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) WITH CORRELATION TO DEMOGRAPHIC PROFILE AND SPIROMETRY PARAMETERS

UA/Cr ratio and ACR are significant independent predictors of COPD severity and their combined use with spirometry may improve risk stratification and clinical decision-making.

P. R., E. Abraham, Ghanshyam Verma · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.